Prelude Therapeutics (PRLD) IPO Opens 33% Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
IPO for Prelude Therapeutics (PRLD) Paused on Volatility After Ramp Higher
September 25, 2020 12:06 PM EDTToday's IPO for Prelude Therapeutics (NASDAQ: PRLD) was paused on volatility after ramping higher. Shares were last up 55% after opening up 33%.
... MorePrelude Therapeutics Inc. (PRLD) Prices 8.325M Share IPO at $19/Sh
September 25, 2020 6:17 AM EDTPrelude Therapeutics Incorporated (NASDAQ: PRLD) today announced the pricing of its initial public offering of 8,325,000 shares of its common stock at a public offering price of $19.00 per share. The gross proceeds to Prelude, before deducting underwriting commissions and offering expenses, are expected to be... More
